Garry E. Menzel
2011 - Regulus Therapeutics
In 2011, Garry E. Menzel earned a total compensation of $442.9K as Chief Operating Officer and Executive Vice President, Finance at Regulus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $64,356 |
|---|---|
| Option Awards | $57,081 |
| Salary | $317,807 |
| Other | $3,661 |
| Total | $442,905 |
Menzel received $317.8K in salary, accounting for 72% of the total pay in 2011.
Menzel also received $64.4K in non-equity incentive plan, $57.1K in option awards and $3.7K in other compensation.
Rankings
In 2011, Garry E. Menzel's compensation ranked 8,413th out of 10,747 executives tracked by ExecPay. In other words, Menzel earned more than 21.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,413 out of 10,747 | 22nd |
Division Manufacturing | 3,104 out of 3,960 | 22nd |
Major group Chemicals And Allied Products | 772 out of 1,033 | 25th |
Industry group Drugs | 559 out of 781 | 28th |
Industry Pharmaceutical Preparations | 431 out of 571 | 25th |
Source: SEC filing on April 30, 2013.
Menzel's colleagues
We found two more compensation records of executives who worked with Garry E. Menzel at Regulus Therapeutics in 2011.